{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:04:42Z","timestamp":1776261882401,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/jhh.2017.38","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T09:20:53Z","timestamp":1495704053000},"page":"627-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hyperkalemia in both surgically and medically treated patients with primary aldosteronism"],"prefix":"10.1038","volume":"31","author":[{"given":"N","family":"Wada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Umakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kamemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"BFjhh201738_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF . Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007; 66: 607\u2013618.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFjhh201738_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallashofski H . Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies - a review of the current literature. Horm Metab Res. 2012; 44: 157\u2013162.","journal-title":"Horm Metab Res."},{"key":"BFjhh201738_CR3","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A et al. Long-term cardio and cerbo-vascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013; 98: 4826\u20134833.","journal-title":"J Clin Endocrinol Metab."},{"key":"BFjhh201738_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11154-011-9162-8","volume":"12","author":"GP Rossi","year":"2011","unstructured":"Rossi GP . Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord. 2011; 12: 27\u201336.","journal-title":"Rev Endocr Metab Disord."},{"key":"BFjhh201738_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1530\/EJE-15-0074","volume":"172","author":"KS Park","year":"2015","unstructured":"Park KS, Kim JH, Ku EJ, Hong AR, Moon MK, Choi SH et al. Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. Eur J Endocrinol. 2015; 172: 725\u2013731.","journal-title":"Eur J Endocrinol."},{"key":"BFjhh201738_CR6","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2012-2234","volume":"97","author":"E Fischer","year":"2012","unstructured":"Fischer E, Hanslik G, Pallauf A, Degenhart C, Linsenmaier U, Beuschlein F et al. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab. 2012; 97: 3965\u20133973.","journal-title":"J Clin Endocrinol Metab."},{"key":"BFjhh201738_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2013.05.017","volume":"424","author":"W-F Chiang","year":"2013","unstructured":"Chiang W-F, Cheng C-J, Wu S-T, Sun G-H, Lin M-Y, Sung C-C et al. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Clin Chim Acta. 2013; 424: 114\u2013118.","journal-title":"Clin Chim Acta."},{"key":"BFjhh201738_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","volume":"65","author":"J Bauersachs","year":"2015","unstructured":"Bauersachs J, Jaisser F, Toto R . Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension 2015; 65: 257\u2013263.","journal-title":"Hypertension"},{"key":"BFjhh201738_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","volume":"58","author":"T Nishikawa","year":"2011","unstructured":"Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N et al. Guidelines for the diagnosis and treatment of primary aldosteronism \u2013The Japan Endocrine Society 2009. Endocr J 2011; 58: 711\u2013721.","journal-title":"Endocr J"},{"key":"BFjhh201738_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2013.80","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH2014). Hypertens Res. 2014; 37: 253\u2013390.","journal-title":"Hypertens Res."},{"key":"BFjhh201738_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/cen.12847","volume":"83","author":"N Umakoshi","year":"2015","unstructured":"Umakoshi N, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fujii Y et al. Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism. Clin Endocrinol (Oxf) 2015; 83: 768\u2013773.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFjhh201738_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kid Dis 2009; 53: 982\u2013992.","journal-title":"Am J Kid Dis"},{"key":"BFjhh201738_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 2008; 9: 509\u2013515.","journal-title":"Expert Opin Pharmacother"},{"key":"BFjhh201738_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme W, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med 1999; 341: 709\u2013717.","journal-title":"New Engl J Med"},{"key":"BFjhh201738_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New Engl J Med 2003; 348: 1309\u20131321.","journal-title":"New Engl J Med"},{"key":"BFjhh201738_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE.114.001104","volume":"7","author":"O Vardeny","year":"2014","unstructured":"Vardeny O, Claggett B, Anand I, Rossignol P, Desai AS, Zannad F et al. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ heart fail 2014; 7: 573\u2013579.","journal-title":"Circ heart fail"},{"key":"BFjhh201738_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","volume":"118","author":"B Pitt","year":"2008","unstructured":"Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R, EPHESUS investigators. Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation 2008; 118: 1643\u20131650.","journal-title":"Circulation"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201738","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/jhh.2017.38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T14:09:30Z","timestamp":1647526170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFjhh201738"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2017.38","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"assertion":[{"value":"20 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}